APIMEDS PHARMACEUTICALS US, INC. Public Float
APIMEDS PHARMACEUTICALS US, INC. (APUS) had Public Float of $7.81 million as of 2025-06-30, per its 10-K filed 2026-05-04.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-05-04
- 2025-06-30: Entity Public Float $7.81M.
- 2024-06-28: Entity Public Float $0.00.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $7.81M 10-K · filed 2026-05-04 |
| 2024-06-28 | $0.00 10-K/A · filed 2025-05-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |